These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9143648)

  • 1. New guidelines proposed for use of RSV immune globulin.
    Am J Health Syst Pharm; 1997 May; 54(9):1025. PubMed ID: 9143648
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prophylaxis of respiratory syncytial virus (RSV) in preterm infants with/without bronchopulmonary dysplasia: hyperimmune globulin (RSV-IGIV) and palivizumab (MEDI-493)].
    Resch B; Müller W
    Klin Padiatr; 1999; 211(6):450-5. PubMed ID: 10592925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory syncytial virus immune globulin intravenous: indications for use. American Academy of Pediatrics Committee on Infectious Diseases, Committee on Fetus and Newborn.
    Pediatrics; 1997 Apr; 99(4):645-50. PubMed ID: 9093323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG). Respiratory Syncytial Virus Immune Globulin Study Group.
    Groothuis JR; Simoes EA; Hemming VG
    Pediatrics; 1995 Apr; 95(4):463-7. PubMed ID: 7700741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of respiratory syncytial virus infection in high risk infants: consensus opinion on the role of immunoprophylaxis with respiratory syncytial virus hyperimmune globulin.
    Meissner HC; Welliver RC; Chartrand SA; Fulton DR; Rodriguez WJ; Groothuis JR
    Pediatr Infect Dis J; 1996 Dec; 15(12):1059-68. PubMed ID: 8970212
    [No Abstract]   [Full Text] [Related]  

  • 6. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group.
    Groothuis JR; Simoes EA; Levin MJ; Hall CB; Long CE; Rodriguez WJ; Arrobio J; Meissner HC; Fulton DR; Welliver RC
    N Engl J Med; 1993 Nov; 329(21):1524-30. PubMed ID: 8413475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis.
    Groothuis JR; Hoopes JM; Hemming VG
    Adv Ther; 2011 Feb; 28(2):110-25. PubMed ID: 21318605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory syncytial virus immune globulin intravenous (human) receives marketing approval in Canada.
    Langley JM
    Can Fam Physician; 1998 Jan; 44():113. PubMed ID: 9481469
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk factors for severe respiratory syncytial virus infection in infants.
    Aujard Y; Fauroux B
    Respir Med; 2002 Apr; 96 Suppl B():S9-14. PubMed ID: 11996403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RespiGam: an RSV immune globulin.
    Oertel MD
    Pediatr Nurs; 1996; 22(6):525-8. PubMed ID: 9087091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory syncytial virus immune globulin intravenous.
    Wandstrat TL
    Ann Pharmacother; 1997 Jan; 31(1):83-8. PubMed ID: 8997472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RSV-IGIV therapy: a cost/benefit analysis.
    Thakur BK; Wu LR; Schaeufele JF
    Pediatrics; 1997 Sep; 100(3 Pt 1):417-8. PubMed ID: 9304108
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhaled nitric oxide for a severe respiratory syncytial virus infection in an infant with bronchopulmonary dysplasia.
    Leclerc F; Riou Y; Martinot A; Storme L; Hue V; Flurin V; Deschildre A; Sadik A
    Intensive Care Med; 1994 Aug; 20(7):511-2. PubMed ID: 7995870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin for preventing respiratory syncytial virus infection.
    Wang EE; Tang NK
    Cochrane Database Syst Rev; 2000; (2):CD001725. PubMed ID: 10796658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prematurity and the burden of influenza and respiratory syncytial virus disease.
    Resch B; Kurath-Koller S; Eibisberger M; Zenz W
    World J Pediatr; 2016 Feb; 12(1):8-18. PubMed ID: 26582294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and treatment of respiratory syncytial virus infections (for advances in pediatric infectious diseases).
    DeVincenzo J
    Adv Pediatr Infect Dis; 1997; 13():1-47. PubMed ID: 9544306
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of respiratory failure with inhaled nitric oxide and high- frequency ventilation in an infant with respiratory syncytial virus pneumonia and bronchopulmonary dysplasia.
    Hoehn T; Krause M; Krueger M; Hentschel R
    Respiration; 1998; 65(6):477-80. PubMed ID: 9817963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience of palivizumab in prophylaxis of respiratory syncytial viral infection in premature children with bronchopulmonary dysplasia].
    Aliamovskaia GA; Keshinian ES
    Vestn Ross Akad Med Nauk; 2012; (12):30, 32-4. PubMed ID: 23530423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.
    Simoes EA; Carbonell-Estrany X
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocarditis in the setting of RSV bronchiolitis.
    Menchise A
    Fetal Pediatr Pathol; 2011; 30(1):64-8. PubMed ID: 21204669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.